- Corporate Officers - I
- Islam Saqib
Insider Trading History of Islam Saqib
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Islam Saqib since 2013.
This trader's CIK number is 1575408.
At the time of last reporting, Islam Saqib was the Chief Executive Officer of Springworks Therapeutics, Inc.. (stock ticker symbol SWTX).
Also see all insider trading activities at Springworks Therapeutics, Inc..
Note that in the past
Islam Saqib also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Passage Bio, Inc. (PASG) by Islam Saqib
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | PASG | 5,000 | $90,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alexion Pharmaceuticals, Inc. (ALXN) by Islam Saqib
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | ALXN | 0 | $0 | 3,444 | $488,316 | 0 | $0 |
2015 | ALXN | 0 | $0 | 11,243 | $2,011,501 | 0 | $0 |
2014 | ALXN | 0 | $0 | 28,125 | $5,358,093 | 28,125 | $2,509,593 |
2013 | ALXN | 0 | $0 | 0 | $0 | 25,000 | $0 |
Yearly summary of insider trading at Springworks Therapeutics, Inc. (SWTX) by Islam Saqib
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | SWTX | 0 | $0 | 137,000 | $7,675,865 | 0 | $0 |
2024 | SWTX | 0 | $0 | 147,000 | $6,053,852 | 0 | $0 |
2021 | SWTX | 0 | $0 | 250,000 | $17,611,589 | 0 | $0 |
Insider trading activities at 3 companies by Islam Saqib:
1. Passage Bio, Inc. (PASG)
2. Alexion Pharmaceuticals, Inc. (ALXN)
3. Springworks Therapeutics, Inc. (SWTX)
Table 1. Insider trading of Passage Bio, Inc. (PASG) by Islam Saqib
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-03-03 | PASG | Buy | 5,000 | 18.00 | 90,000 |
Table 2. Insider trading of Alexion Pharmaceuticals, Inc. (ALXN) by Islam Saqib
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-02-08 | ALXN | Sale | 1,474 | 138.90 | 204,731 |
2016-02-05 | ALXN | Sale | 1,970 | 143.95 | 283,585 |
2015-12-08 | ALXN | Sale | 950 | 190.00 | 180,500 |
2015-11-02 | ALXN | Sale | 975 | 180.00 | 175,500 |
2015-10-26 | ALXN | Sale | 1,558 | 168.44 | 262,429 |
2015-04-27 | ALXN | Sale | 6,032 | 181.57 | 1,095,230 |
2015-03-02 | ALXN | Sale | 228 | 180.34 | 41,117 |
2015-02-10 | ALXN | Sale | 1,500 | 171.15 | 256,725 |
2014-11-03 | ALXN | Option Ex | 28,125 | 89.23 | 2,509,593 |
2014-11-03 | ALXN | Sale | 28,125 | 190.51 | 5,358,093 |
2013-04-24 | ALXN | Option Ex | 25,000 | .00 | 0 |
Table 3. Insider trading of Springworks Therapeutics, Inc. (SWTX) by Islam Saqib
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-03-03 | SWTX | Sale | 49,000 | 55.08 | 2,698,822 |
2025-02-20 | SWTX | Sale | 29,328 | 60.67 | 1,779,300 |
2025-02-14 | SWTX | Sale | 10,672 | 59.92 | 639,487 |
2025-02-10 | SWTX | Sale | 48,000 | 53.30 | 2,558,256 |
2024-12-02 | SWTX | Sale | 49,000 | 41.59 | 2,037,959 |
2024-09-03 | SWTX | Sale | 49,000 | 41.09 | 2,013,508 |
2024-06-03 | SWTX | Sale | 49,000 | 40.87 | 2,002,385 |
2021-10-20 | SWTX | Sale | 10,083 | 58.67 | 591,529 |
2021-10-18 | SWTX | Sale | 38,340 | 58.59 | 2,246,493 |
2021-10-19 | SWTX | Sale | 14,077 | 58.81 | 827,868 |
2021-07-19 | SWTX | Sale | 43,928 | 76.09 | 3,342,437 |
2021-07-20 | SWTX | Sale | 18,572 | 77.68 | 1,442,747 |
2021-04-19 | SWTX | Sale | 38,425 | 69.04 | 2,652,823 |
2021-04-20 | SWTX | Sale | 24,075 | 66.39 | 1,598,291 |
2021-01-19 | SWTX | Sale | 60,301 | 78.54 | 4,736,221 |
2021-01-20 | SWTX | Sale | 2,199 | 78.75 | 173,180 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Islam Saqib
(Chief Executive Officer of Springworks Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.